Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.3538
-0.0345 (-8.88%)
Oct 30, 2026, 2:02 PM EDT - Market open
Neumora Therapeutics Employees
Neumora Therapeutics had 63 employees as of June 30, 2026. The number of employees decreased by 33 or 34.38% compared to the same quarter last year. That makes Neumora Therapeutics the 33,946th largest employer in the world and 4,479th in the United States.
Employees
63
Change (1Y)
-33
Growth (1Y)
-34.38%
Revenue / Employee
n/a
Profits / Employee
-$3,376,905
Market Cap
66.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 63 | -33 | -34.38% |
| Mar 31, 2026 | 92 | -11 | -10.68% |
| Dec 31, 2025 | 96 | -14 | -12.73% |
| Sep 30, 2025 | 95 | -14 | -12.84% |
| Jun 30, 2025 | 96 | -12 | -11.11% |
| Mar 31, 2025 | 103 | -17 | -14.17% |
| Dec 31, 2024 | 110 | -14 | -11.29% |
| Sep 30, 2024 | 109 | -1 | -0.91% |
| Jun 30, 2024 | 108 | -2 | -1.82% |
| Mar 31, 2024 | 120 | 12 | 11.11% |
| Dec 31, 2023 | 124 | 30 | 31.91% |
| Jun 30, 2023 | 110 | 16 | 17.02% |
| Mar 31, 2023 | 108 | 14 | 14.89% |
| Dec 31, 2022 | 94 | 6 | 6.82% |
| Mar 31, 2022 | 94 | 41 | 77.36% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Gossamer Bio | 162 |
| Inovio Pharmaceuticals | 112 |
| Fortress Biotech | 78 |
| Acrivon Therapeutics | 76 |
| Cardiff Oncology | 31 |
| Cognition Therapeutics | 14 |
| Cingulate | 14 |
NMRA News
- 1 day ago - Neumora Therapeutics price target lowered to $3 from $4 at Mizuho - TheFly
- 2 months ago - Neumora CEO transition not a surprise, says H.C. Wainwright - TheFly
- 2 months ago - Neumora Therapeutics reports Q2 EPS (23c), consensus (24c) - TheFly
- 2 months ago - Neumora Therapeutics CEO Paul Berns to switch roles, Joshua Pinto to succeed - TheFly
- 2 months ago - Neumora Therapeutics Slides: Company presentation - Filings
- 2 months ago - Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Neumora Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Neumora Therapeutics Quarterly report: Q2 2026 - Filings